
AGL Valuation
agilon health inc
- Overview
- Forecast
- Valuation
- Earnings
AGL Relative Valuation
AGL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AGL is overvalued; if below, it's undervalued.
Historical Valuation
agilon health inc (AGL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.06 is considered Undervalued compared with the five-year average of -29.24. The fair price of agilon health inc (AGL) is between 6.04 to 53.41 according to relative valuation methord. Compared to the current price of 0.87 USD , agilon health inc is Undervalued By 85.58%.
Relative Value
Fair Zone
6.04-53.41
Current Price:0.87
85.58%
Undervalued
-2.84
PE
1Y
3Y
5Y
Trailing
Forward
-0.71
EV/EBITDA
agilon health inc. (AGL) has a current EV/EBITDA of -0.71. The 5-year average EV/EBITDA is 113.83. The thresholds are as follows: Strongly Undervalued below -913.50, Undervalued between -913.50 and -399.83, Fairly Valued between 627.50 and -399.83, Overvalued between 627.50 and 1141.17, and Strongly Overvalued above 1141.17. The current Forward EV/EBITDA of -0.71 falls within the Historic Trend Line -Fairly Valued range.
-0.33
EV/EBIT
agilon health inc. (AGL) has a current EV/EBIT of -0.33. The 5-year average EV/EBIT is -96.13. The thresholds are as follows: Strongly Undervalued below -295.63, Undervalued between -295.63 and -195.88, Fairly Valued between 3.63 and -195.88, Overvalued between 3.63 and 103.38, and Strongly Overvalued above 103.38. The current Forward EV/EBIT of -0.33 falls within the Historic Trend Line -Fairly Valued range.
0.06
PS
agilon health inc. (AGL) has a current PS of 0.06. The 5-year average PS is 2.08. The thresholds are as follows: Strongly Undervalued below -1.94, Undervalued between -1.94 and 0.07, Fairly Valued between 4.09 and 0.07, Overvalued between 4.09 and 6.10, and Strongly Overvalued above 6.10. The current Forward PS of 0.06 falls within the Undervalued range.
-4.74
P/OCF
agilon health inc. (AGL) has a current P/OCF of -4.74. The 5-year average P/OCF is 650.37. The thresholds are as follows: Strongly Undervalued below -1955.45, Undervalued between -1955.45 and -652.54, Fairly Valued between 1953.28 and -652.54, Overvalued between 1953.28 and 3256.19, and Strongly Overvalued above 3256.19. The current Forward P/OCF of -4.74 falls within the Historic Trend Line -Fairly Valued range.
-4.35
P/FCF
agilon health inc. (AGL) has a current P/FCF of -4.35. The 5-year average P/FCF is 734.42. The thresholds are as follows: Strongly Undervalued below -4839.19, Undervalued between -4839.19 and -2052.38, Fairly Valued between 3521.23 and -2052.38, Overvalued between 3521.23 and 6308.04, and Strongly Overvalued above 6308.04. The current Forward P/FCF of -4.35 falls within the Historic Trend Line -Fairly Valued range.
agilon health inc (AGL) has a current Price-to-Book (P/B) ratio of 0.84. Compared to its 3-year average P/B ratio of 5.25 , the current P/B ratio is approximately -84.00% higher. Relative to its 5-year average P/B ratio of 4.07, the current P/B ratio is about -79.36% higher. agilon health inc (AGL) has a Forward Free Cash Flow (FCF) yield of approximately -19.96%. Compared to its 3-year average FCF yield of -5.52%, the current FCF yield is approximately 261.77% lower. Relative to its 5-year average FCF yield of -4.20% , the current FCF yield is about 375.17% lower.
0.87
P/B
Median3y
5.25
Median5y
4.07
-19.96
FCF Yield
Median3y
-5.52
Median5y
-4.20
Competitors Valuation Multiple
The average P/S ratio for AGL's competitors is 1.63, providing a benchmark for relative valuation. agilon health inc Corp (AGL) exhibits a P/S ratio of 0.06, which is -96.37% above the industry average. Given its robust revenue growth of -5.92%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of AGL decreased by 78.15% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -2.07 to -7.48.
The secondary factor is the Revenue Growth, contributed -5.92%to the performance.
Overall, the performance of AGL in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

NMM
Navios Maritime Partners LP
44.150
USD
+1.31%

QNST
QuinStreet Inc
14.620
USD
+0.76%

QUBT
Quantum Computing Inc
16.600
USD
+0.85%

DAWN
Day One Biopharmaceuticals Inc
6.140
USD
+4.07%

OLO
Olo Inc
10.200
USD
-0.10%

KW
Kennedy-Wilson Holdings Inc
7.720
USD
+1.45%

SPH
Suburban Propane Partners LP
18.390
USD
+2.45%

AIV
Apartment Investment and Management Co
7.610
USD
-3.79%

MFIC
MidCap Financial Investment Corp
13.060
USD
+3.49%

BY
Byline Bancorp Inc
27.010
USD
+3.80%
FAQ

Is agilon health inc (AGL) currently overvalued or undervalued?
agilon health inc (AGL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.06 is considered Undervalued compared with the five-year average of -29.24. The fair price of agilon health inc (AGL) is between 6.04 to 53.41 according to relative valuation methord. Compared to the current price of 0.87 USD , agilon health inc is Undervalued By 85.58% .

What is agilon health inc (AGL) fair value?

How does AGL's valuation metrics compare to the industry average?

What is the current P/B ratio for agilon health inc (AGL) as of Aug 13 2025?

What is the current FCF Yield for agilon health inc (AGL) as of Aug 13 2025?

What is the current Forward P/E ratio for agilon health inc (AGL) as of Aug 13 2025?
